ScholarIQanswers from OpenAlex

Real-world efficacy of long-term teduglutide use in pediatric patients with short bowel syndrome

PaperCitations, authors & open-access status

Real-world efficacy of long-term teduglutide use in pediatric patients with short bowel syndrome is a paper indexed in ScholarIQ from OpenAlex.

How many citations does Real-world efficacy of long-term teduglutide use in pediatric patients with short bowel syndrome have?

ScholarIQcitation count

Real-world efficacy of long-term teduglutide use in pediatric patients with short bowel syndrome has 1 citations in the OpenAlex counts ScholarIQ stores.

When was Real-world efficacy of long-term teduglutide use in pediatric patients with short bowel syndrome published?

ScholarIQyear

Real-world efficacy of long-term teduglutide use in pediatric patients with short bowel syndrome has 2025 year in the ScholarIQ index.

What is the open-access status of Real-world efficacy of long-term teduglutide use in pediatric patients with short bowel syndrome?

ScholarIQoa status

Real-world efficacy of long-term teduglutide use in pediatric patients with short bowel syndrome has diamond oa status in the ScholarIQ index.

What is the DOI of Real-world efficacy of long-term teduglutide use in pediatric patients with short bowel syndrome?

ScholarIQdoi

The DOI for Real-world efficacy of long-term teduglutide use in pediatric patients with short bowel syndrome is on the source record.

What is the PMID of Real-world efficacy of long-term teduglutide use in pediatric patients with short bowel syndrome?

ScholarIQpmid

The PMID for Real-world efficacy of long-term teduglutide use in pediatric patients with short bowel syndrome is on the source record.

What is the OpenAlex record for Real-world efficacy of long-term teduglutide use in pediatric patients with short bowel syndrome?

ScholarIQopenalex

The OpenAlex for Real-world efficacy of long-term teduglutide use in pediatric patients with short bowel syndrome is on the source record.

Related on ScholarIQ

470M+ articles · 14-day free trial